← Back to Screener
Solventum Corporation (SOLV)
Price$68.88
Favorite Metrics
Price vs S&P 500 (26W)-8.58%
Price vs S&P 500 (4W)-2.84%
Market Capitalization$11.98B
P/E Ratio (Annual)7.70x
All Metrics
P/CF (Annual)32.47x
Book Value / Share (Quarterly)$29.10
P/TBV (Annual)5.59x
Revenue Growth (3Y)0.79%
Cash Flow / Share (Quarterly)$-0.06
Price vs S&P 500 (YTD)-15.44%
Gross Margin (TTM)53.57%
Net Profit Margin (TTM)18.69%
EPS (TTM)$8.87
10-Day Avg Trading Volume1.29M
EPS Excl Extra (TTM)$8.87
EPS (Annual)$8.88
ROI (Annual)15.43%
Gross Margin (Annual)53.57%
Net Profit Margin (5Y Avg)15.06%
Cash / Share (Quarterly)$5.06
P/E Basic Excl Extra (TTM)7.70x
Revenue Growth QoQ (YoY)-3.71%
P/E Normalized (Annual)7.70x
ROA (Last FY)10.89%
Revenue Growth TTM (YoY)0.86%
EBITD / Share (TTM)$14.54
ROE (5Y Avg)16.41%
Operating Margin (TTM)25.20%
Cash Flow / Share (Annual)$-0.06
P/B Ratio2.37x
P/B Ratio (Quarterly)2.72x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.94x
Net Interest Coverage (TTM)5.94x
ROA (TTM)10.76%
EPS Growth QoQ (YoY)108.50%
EV / EBITDA (TTM)6.33x
EPS Incl Extra (Annual)$8.88
Current Ratio (Annual)1.23x
Quick Ratio (Quarterly)0.89x
3-Month Avg Trading Volume1.19M
52-Week Price Return1.92%
EV / Free Cash Flow (Annual)20.33x
P/E Incl Extra (TTM)7.70x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$14.16
P/S Ratio (Annual)1.44x
Asset Turnover (Annual)0.58x
52-Week High$88.20
Operating Margin (5Y Avg)20.44%
EPS Excl Extra (Annual)$8.88
26-Week Price Return-4.60%
Quick Ratio (Annual)0.84x
13-Week Price Return-19.36%
Total Debt / Equity (Annual)1.00x
Current Ratio (Quarterly)1.23x
Enterprise Value$16,139.302
Asset Turnover (TTM)0.58x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)3.81x
Pretax Margin (Annual)20.58%
Cash / Share (Annual)$5.06
3-Month Return Std Dev31.79%
Gross Margin (5Y Avg)56.94%
Net Income / Employee (TTM)$0
ROE (Last FY)30.82%
Net Interest Coverage (Annual)5.94x
EPS Basic Excl Extra (Annual)$8.88
P/FCF (TTM)127.47x
Receivables Turnover (TTM)8.01x
EV / Free Cash Flow (TTM)327.30x
Total Debt / Equity (Quarterly)1.00x
EPS Incl Extra (TTM)$8.87
Receivables Turnover (Annual)8.01x
ROI (TTM)14.53%
P/S Ratio (TTM)1.44x
Pretax Margin (5Y Avg)18.42%
Revenue / Share (Annual)$47.49
Tangible BV / Share (Annual)$14.16
Forward P/E10.72x
Price vs S&P 500 (52W)-27.91%
P/E Ratio (TTM)7.70x
EPS Growth TTM (YoY)221.66%
Year-to-Date Return-12.80%
5-Day Price Return4.41%
EPS Normalized (Annual)$8.88
ROA (5Y Avg)8.82%
Net Profit Margin (Annual)18.69%
Month-to-Date Return5.82%
EBITD / Share (Annual)$14.54
EPS Growth (3Y)4.46%
Operating Margin (Annual)25.21%
LT Debt / Equity (Annual)1.00x
P/CF (TTM)32.47x
ROI (5Y Avg)10.98%
P/E Excl Extra (TTM)7.70x
LT Debt / Equity (Quarterly)1.00x
EPS Basic Excl Extra (TTM)$8.87
P/TBV (Quarterly)5.59x
P/B Ratio (Annual)2.72x
Inventory Turnover (TTM)3.81x
Pretax Margin (TTM)20.58%
Book Value / Share (Annual)$29.10
Price vs S&P 500 (13W)-20.05%
Beta0.89x
P/FCF (Annual)14.88x
Revenue / Share (TTM)$47.33
ROE (TTM)36.74%
52-Week Low$62.38
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.71
3.76
3.76
3.67
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
SOLVSolventum Corporation | 1.44x | — | 53.57% | 25.20% | $68.88 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Solventum is a diversified healthcare company providing innovative medical solutions across three core areas: wound care and surgical supplies, dental products, and health information systems. The company leverages material science, data science, and digital technologies to serve hospitals, dental practices, and healthcare providers. Solventum generates the majority of its revenue in the United States while maintaining a growing international presence.